glp-1 news september 2025 Pipeline Update: May - Prime Therapeutics 2025 dominates for GLP-1 trial

These include Ozempic (semaglutide) and Trulicity (dulaglutide)

And while you might experience some discomfort at the time, this will probably subside after just a few seconds

We have outlined key areas, notably ED treatment, where a well-designed clinical trial involving PT-141 would illuminate more details regarding its safety in vivo testing

Most seniors notice improved energy, immunity, or skin clarity within 24 weeks of daily use

Mounjaro is not contraindicated for bipolar disorder, but requires careful individual assessment and close supervision by your GP and mental health team

WADA Status: According to the World Anti-Doping Agency (WADA), all non-approved substances fall under the S0 category (Non-Approved Substances) and are prohibited in sport at all times even if they are not specifically named on the prohibited list